Melbourne, Victoria, Australia.
+61 3 8559 6530
Subscribe
Email Us
Collaborate Now

Melanoma Journal Articles for December 2018

Dove press

Pathological complete response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with unresectable BRAF V600E-mutant malignant melanoma of the gallbladder

Authors Yu Z, Quiroz E, Shen Y, Jaiyesimi IA

Received 13 June 2018

Accepted for publication 16 August 2018

Published 4 December 2018 Volume 2018:11 Pages 8723—8728

DOI https://doi.org/10.2147/OTT.S177111

Cochrane Review

Dinnes J, Deeks JJ, Saleh D, Chuchu N, Bayliss SE, Patel L, Davenport C, Takwoingi Y, Godfrey K, Matin RN, Patalay R, Williams HC, Cochrane Skin Cancer Diagnostic Test Accuracy Group. Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No.: CD013190. DOI: 10.1002/14651858.CD013190.

FASEB Journal

Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032

Kohya Kudo, Atsuko Yoneda, Daiki Sakiyama, Kai Kojima, Takeki Miyaji, Miku Yamazaki, Saori Yaita, Takuya Hyodo, Reiko Satow, and Kiyoko Fukami

Published Online: 3 Dec 2018   https://doi.org/10.1096/fj.201800664RR

Dove Press

SFRP5 inhibits the migration and invasion of melanoma cells through Wnt signaling pathway

Authors Chen Y, Zou D, Wang N, Tan T, Liu Y, Zhao Q, Pu Y, Thapa RJ, Chen J

Received 26 July 2018

Accepted for publication 1 November 2018

Published 6 December 2018 Volume 2018:11 Pages 8761—8772

DOI https://doi.org/10.2147/OTT.S181146

PNAS

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

  1. Stephen Hodi, Martin C. Mihm, Robert J. Soiffer, Frank G. Haluska, Marcus Butler, Michael V. Seiden, Thomas Davis, Rochele Henry-Spires, Suzanne MacRae, Ann Willman, Robert Padera, Michael T. Jaklitsch, Sridhar Shankar, Teresa C. Chen, Alan Korman, James P. Allison, and Glenn Dranoff

PNAS April 15, 2003 100 (8) 4712-4717; https://doi.org/10.1073/pnas.0830997100

Dove Press

Resveratrol induces apoptosis in human melanoma cell through negatively regulating Erk/PKM2/Bcl-2 axis

Authors Zhao H, Han L, Jian Y, Ma Y, Yan W, Chen X, Xu H, Li L

Received 11 September 2018

Accepted for publication 14 November 2018

Published 11 December 2018 Volume 2018:11 Pages 8995—9006

DOI https://doi.org/10.2147/OTT.S186247

BMC Cancer

Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells

Marina Teras†, Edda Viisileht†, Merlis Pahtma-Hall, Airi Rump, Viiu Paalme, Pille Pata, Illar Pata, Christelle Langevin and Sirje Rüütel Boudinot

†Contributed equally

BMC Cancer 2018 18:1237

https://doi.org/10.1186/s12885-018-5090-2

  • Received: 5 January 2018
  • Accepted: 14 November 2018
  • Published: 10 December 2018

IJC

Cancer Epidemiology

 Circulating insulin?like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition

Kathryn E. Bradbury, Paul N. Appleby, Sarah J. Tipper, Ruth C. Travis, Naomi E. Allen, Marina Kvaskoff,  Kim Overvad, Anne Tjønneland, Jytte Halkjær, Iris Cervenka

First published: 07 September 2018

https://doi.org/10.1002/ijc.31854

Journal of Experimental & Clinical Cancer Research

Targeted radiotherapy of pigmented melanoma with 131I-5-IPN

Xiaodong Xu†, Lujie Yuan†, Yongkang Gai, Qingyao Liu, Lianglan Yin, Yaqun Jiang, Yichun Wang, Yongxue Zhang and Xiaoli Lan

†Contributed equally

Journal of Experimental & Clinical Cancer Research 201837:306

https://doi.org/10.1186/s13046-018-0983-0

  • Received: 5 October 2018
  • Accepted: 26 November 2018
  • Published: 11 December 2018

Carcinogenesis 

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma

Laura Carminati Denise Pinessi Patrizia Borsotti Lucia Minoli Raffaella GiavazziMaurizio D’Incalci Dorina Belotti Giulia Taraboletti

https://doi.org/10.1093/carcin/bgy177

Published:

13 December 2018

Science Immunology

Generation and molecular recognition of melanoma-associated antigen-specific human ?? T cells

  1. Patricia M. Benveniste1,*, 
  2. Sobhan Roy2,*, 
  3. Munehide Nakatsugawa3, 
  4. Edward L. Y. Chen1, 
  5. Linh Nguyen3, 
  6. Douglas G. Millar3, 
  7. Pamela S. Ohashi3, 
  8. Naoto Hirano3,4, 
  9. Erin J. Adams2,†and 
  10. Juan Carlos Zúñiga-Pflücker1,3,4,†

 

Science Immunology  14 Dec 2018:
Vol. 3, Issue 30, eaav4036
DOI: 10.1126/sciimmunol.aav4036

JAMA

Original Investigation

December 2018

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

Caroline C. Kim, MD1; Elizabeth G. Berry, MD2,3; Michael A. Marchetti, MD4; et alSusan M. Swetter, MD5,6; Geoffrey Lim, MD7; Douglas Grossman, MD, PhD8,9; Clara Curiel-Lewandrowski, MD10; Emily Y. Chu, MD, PhD11; Michael E. Ming, MD, MSCE11; Kathleen Zhu, BA12; Meera Brahmbhatt, MD2,13; Vijay Balakrishnan, BS2,3; Michael J. Davis, BMus2,3; Zachary Wolner, BA4; Nathaniel Fleming, BA5,6; Laura K. Ferris, MD, PhD7; John Nguyen, BA14; Oleksandr Trofymenko, BA10; Yuan Liu, PhD2; Suephy C. Chen, MD, MS2,3; for the Pigmented Lesion Subcommittee, Melanoma Prevention Working Group

JAMA Dermatol. 2018;154(12):1401-1408. doi:10.1001/jamadermatol.2018.3359

Dove Press

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

Authors Sun J, Zager JS, Eroglu Z

Received 21 August 2018

Accepted for publication 17 November 2018

Published 14 December 2018 Volume 2018:11 Pages 9081—9089

DOI https://doi.org/10.2147/OTT.S171693

Wilson B.S. et al. (1982) Immunochemical Analysis of the Antigenic Profile of Human Melanoma Cells with Monoclonal Antibodies. In: Reisfeld R.A., Ferrone S. (eds) Melanoma Antigens and Antibodies. Springer, Boston, MA

 

  • DOIhttps://doi.org/10.1007/978-1-4684-4079-9_22

 

  • Publisher NameSpringer, Boston, MA

 

  • Print ISBN978-1-4684-4081-2
  • Online ISBN978-1-4684-4079-9

Annals of Oncology

The predictive value of 18F-FDG PET/CT after ipilimumab for treatment response evaluation in metastatic melanoma patients 

S Vari A Annovazzi R Pasqualoni R Sciuto D Giannarelli F Cognetti V Ferraresi

Annals of Oncology, Volume 29, Issue suppl_10, 1 December 2018, mdy486.019, https://doi.org/10.1093/annonc/mdy486.019

Published:17 December 2018

International Journal of Cancer

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro?invasive exosomes

Dajiang Guo, Goldie Y. L. Lui, Siew Li Lai, James S. Wilmott, Shweta Tikoo, Louise A. Jackett, Camelia Quek, Darren L. Brown, Danae M. Sharp, Rain Y.Q. Kwan, Diego Chacon, et. Al.

First published: 17 December 2018

https://doi.org/10.1002/ijc.32064

JAMA

December 19, 2018

Risk Factors of Subsequent Primary Melanomas in Austria

Christoph Müller, MD1; Judith Wendt, MD, PhD1; Sabine Rauscher, MSc1; et alRaute Sunder-Plassmann, MD2; Erika Richtig, MD3; Ingrid Fae, MSc4; Gottfried Fischer, MD4; Ichiro Okamoto, MD1

JAMA Dermatol. Published online December 19, 2018. doi:10.1001/jamadermatol.2018.4645

Journal of Biomechanics

Integration of hyper-compliant microparticles into a 3D melanoma tumor model

Manisha K. Shah, Elizabeth A. Leary, Eric M. Darling

https://doi.org/10.1016/j.jbiomech.2018.10.018

Frontiers in ONCOLOGY

ORIGINAL RESEARCH ARTICLE

Front. Oncol., 19 November 2018 | https://doi.org/10.3389/fonc.2018.00530

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma

Taku Fujimura1*, Yota Sato1, Kayo Tanita1, Yumi Kambayashi1, Atsushi Otsuka2, Yasuhiro Fujisawa3, Koji Yoshino4, Shigeto Matsushita5, Takeru Funakoshi6, Hiroo Hata7, Yuki Yamamoto8, Hiroshi Uchi9, Yumi Nonomura2, Ryota Tanaka3, Megumi Aoki5, Keisuke Imafuku7, Hisako Okuhira8, Naoko Wada9, Hiroyuki Irie2, Takanori Hidaka1, Akira Hashimoto1 and Setsuya Aiba1

Dove Press

LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway

Authors Gao J, Zeng K, Liu Y, Gao L, Liu L

Received 15 August 2018

Accepted for publication 10 November 2018

Published 24 December 2018 Volume 2019:12 Pages 169—179

DOI https://doi.org/10.2147/OTT.S184078

JAAD

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: will it help or harm patients?

Michael A. Marchetti, MD, Edmund K. Bartlett, MD, Stephen W. Dusza, DrPH, Christopher K. Bichakjian, MD

DOI: https://doi.org/10.1016/j.jaad.2018.11.063

BMC

Journal of Medical Case Reports

Rhegmatogenous retinal detachment in a patient with choroidal melanoma simulating choroidal detachment: a case report

Satoru Kase, Yuka Suimon, Kan Ishijima andSusumu Ishida

Journal of Medical Case Reports201812:389

https://doi.org/10.1186/s13256-018-1921-7

  • Received: 18 March 2018
  • Accepted: 11 November 2018
  • Published: 25 December 2018

Dove Press

Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study

Authors Zhang D, Dong Y, Sun X, Yuan S, Yu J

Received 11 September 2018

Accepted for publication 3 December 2018

Published 27 December 2018 Volume 2019:11 Pages 339—346

DOI https://doi.org/10.2147/CMAR.S187208

Nature

Letter | Published: 31 December 2018

Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin

Simone L. Park, Anthony Buzzai, Jai Rautela, Jyh Liang Hor, Katharina Hochheiser, Maike Effern, Nathan McBain, Teagan Wagner, Jarem Edwards, Robyn McConville, James S. Wilmott, Richard A. Scolyer, Thomas Tüting, Umaimainthan Palendria, David Gyorki, Scott N. Mueller, Nicholas D. Huntington, Sammy Bedoui, Michael Hölzel, Laura K. Mackay, Jason Waithman & Thomas Gebhardt

Nature (2018

Menu